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ABSTRACT

ELUCIDATING THE MECHANICAL, STRUCTURAL, FUNCTIONAL, AND MOLECULAR
MECHANISMS INVOLVED IN IRREVERSIBLE VACULAR CHANGES IN AORTIC
COARCTATION
Brandon J. Wegter
Marquette University, 2017

Coarctation of the aorta (CoA) is a constriction of the thoracic aorta and is one of the
most common congenital cardiovascular defects. Treatment by surgical correction has saved the
lives of thousands of children, but many still have a reduced lifespan due to hypertension.
Previous results using our novel rabbit model showed that the current treatment guideline of a 20
mmHg blood pressure gradient (BPG) induces irreversible vascular changes, which persisted
despite correction. Preliminary data of the downregulation of natriuretic peptide receptor C
(NPR-C) in proximal aortic tissue of human patients with CoA serves as the possible underlying
mechanism for persistent morbidity. The purpose of this investigation was to determine the
minimum severity and duration of CoA that causes these persistent vascular changes, and to
correlate these changes to NPR-C expression and activity.
Rabbits underwent CoA at 10 weeks of age to induce 5, 10, or 20 mmHg BPG severity
using permanent or dissolvable sutures, thereby replicating untreated or corrected (i.e. treated)
CoA, respectively. Additionally, 21-day and 7-day dissolvable sutures were used in the corrected
groups to alter the duration that the CoA is present. Computational fluid dynamics (CFD)
simulations using subject-specific control data at 32 weeks were performed on idealized CoA
models of each severity to quantify blood pressure (BP), wall tension, and wall shear stress
(WSS). Arterial structure and function were evaluated proximal and distal to the CoA, in both
aortic as well as carotid and femoral arteries, via histology, immunohistochemistry (IHC), and
myograph analysis. These results were then correlated to NPR-C expression and function,
assessed with additional IHC and myography.
Results revealed that there is a distinct increase in the BP and area of elevated tension in
the proximal aorta as the severity of CoA was increased, while in the distal aorta there was a
significant increase in the extent and magnitude of elevated WSS. These adverse mechanical
stimuli lead to vascular remodeling, significantly less vessel compliance, and severe endothelial
dysfunction in the proximal aorta when the BPG was larger than 10 mmHg. An identical
threshold in the carotid artery resulted in increased arterial stiffness, while endothelial
dysfunction did not occur. Correcting a CoA with a BPG of 10 mmHg or higher within 7 days
does prevent significant vascular remodeling and significant loss in vessel compliance, but it does
not mitigate endothelial dysfunction. Aortic NPR-C expression is significantly decreased in the
presence of CoA, and is not restored following alleviation of a 10 mmHg BPG. The presence of a
CoA more severe than 10 mmHg resulted in impaired NPR-C function in all vasculature proximal
to the coarctation, but it remains unclear whether alleviation of the CoA restores NPR-C function.
Collectively, these results suggest a BPG ≤10 mmHg may be the threshold warranting
correction of CoA, which is considerably less than the current clinical treatment guideline of 20
mmHg. Furthermore, preliminary results suggest NPR-C expression and function is reduced and
impaired, respectively, due to a CoA more severe than this proposed threshold. This finding
suggests NPR-C may be a promising therapeutic target for the vascular adversities involved with
CoA and hypertension.
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CHAPTER 1: INTRODUCTION
1.1 Presentation of coarctation of the Aorta

Coarctation of the aorta (CoA) is one of the most common congenital heart diseases
(CHD) in the United States, accounting for 5%-7% of all CHD and presenting in approximately 4
out of every 10,000 births [1]. CoA is characterized by a constriction in the aorta, typically
discrete and located just distal to the left subclavian artery in the descending thoracic region
(Figure 1). CoA can, however, occur as a long narrowing as well as originate in the aortic arch
[2]. While CoA can occur as an isolated cardiac defect, many times it is associated with
ventricular septal defect, aortic arch hypoplasia, hypoplastic left heart syndrome, and most
commonly bicuspid aortic valve [3]. As with many CHD the specific cause of CoA remains
elusive, but is believed to occur during the development of the great arteries as neonates [1, 3].
Although discovering CoA prenatally is beneficial for optimal treatment planning, it is
notoriously difficult to diagnose due to the incomplete development of the great arteries [4, 5].
This results in roughly 60% of CoA neonates leaving the hospital without a diagnosis, only to
return later when symptoms have appeared [6]. The most notable symptom is hypertension, but
shortness of breath, headaches, chest pain, dizziness, and nosebleeds can also occur [7].
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Normal

CoA

Figure 1. Schematic comparing a normal thoracic aorta to one that has a discrete coarctation in
the descending thoracic region (adapted from Coarctation of the Aorta[8]).

The narrowing in CoA subsequently creates adverse biomechanical effects in the
vasculature upstream from the coarctation, most notably a substantial increase in BP. The clinical
severity of CoA is based on the measured blood pressure gradient (BPG) across the stenosis.
Currently, a BPG of 20 mmHg is the putative guideline for surgical intervention and repair [9].
Furthermore, a coarctation that is less severe is often not detected until an investigation into a
diagnoses of hypertension, or other cardiovascular issue, in older children or adult patients [1].

1.2 Repair of CoA
The first surgical repair of CoA was reported in 1944, in which resection and end-to-end
anastomosis was conducted [10]. This technique yielded relatively high recoarctation rates of 2441%, so in 1977 a modification was made in which a longer section of tissue was anastomosed
[7]. This new technique, known as extended end-to-end anastomosis (Figure 2, top), has much
lower rates of recoarctation (4-11%) and is the preferred method of surgical repair today [11]. To
avoid the complications and invasiveness of surgical intervention, transcatheter options for repair
were developed. Particularly, balloon angioplasty and stent implantation were first reported in
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1982 and 1991, respectively. Balloon angioplasty is conducted by dilation of the coarctation with
a catheterized balloon (Figure 2, bottom-left) and has comparable rates of recoarctation (~15%)
to surgical repair, but has a relatively elevated risk of aneurism formation (24%); making it
preferred for recurrent coarctation intervention instead of native CoA [12]. Treatment of CoA via
endovascular stent placement (Figure 2, bottom-right) has higher long-term recoarctation rates
(~20%) than balloon angioplasty, but does have a significantly reduced risk of aneurysm (1%)
[12, 79]. Based on these outcomes, stent implantation is preferred over balloon angioplasty for
long-term repair, but undesirable in infants due to growth [13]. While surgical repair has vastly
improved the mortality rates in CoA patients, long-term cardiovascular morbidity persists;
commonly in the form of refractory hypertension. Two separate studies of long-term outcomes in
corrected CoA patients found that the average lifespan was only 38 years of age in 1989[14].
Although more recent literature suggests life expectancies closer to normal, collectively the life
expectancy in corrected CoA patients is decades less than that of the normal population,
warranting a need for research to better understand this disease.
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Figure 2. Schematic of the extended resection and end-to-end anastomosis surgical repair
technique (Top, adapted from Repair of coarctation of the aorta [15]). Diagram of balloon
angioplasty to repair CoA (Bottom-left, adapted from Coarctation of the Aorta HD [16]).
Depiction of endovascular stent placement to repair CoA (Bottom-right, adapted from Nance et
al, 2015 [17]).

1.3 The influence of mechanical stimuli on vascular structure
Mechanical stimuli have been shown to influence the development and progression of
cardiovascular disease (CVD). For example, it has been demonstrated that wall tension is
indicative of the risk of hypertension and aneurysm formation; while research has also shown that
areas of low WSS have been correlated to atherogenesis and inflammation in the vasculature of
animals and humans [18-20]. Under normal physiological conditions, arterial myogenic activity is
able to counteract sustained changes in flow by dilating or constricting, and therefore maintain a
constant wall shear stress. When the BP is higher than normal for an extended period, as seen in
hypertension, the strain and tension imparted on the vessel wall increases. Subsequent vascular
remodeling occurs to increase the medial thickness so that the vessel is able to maintain its
homeostatic wall stress level [19]. Remodeling from these prolonged elevations in vessel wall
strain and tension are also contributors to increasing arterial stiffness due to the degradation of
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elastin, which is then replaced with less-compliant collagen [19]. This medial thickening and
restructuring could be attributed to a change in smooth muscle cell (SMC) phenotype expression,
which ultimately determines smooth muscle (SM) function [21]. Specifically, the contractility of
SM is highly dependent on the differentiation state of the associated cells, as fully differentiated
(i.e. mature) SMC’s proliferate slowly and are wired for contraction only [21]. It has been
demonstrated that a change from the fully matured phenotype is linked to vascular injury or
disease, in which the SMC’s change to a proliferative phenotype that ultimately modifies SM
structure and function, and this alteration may occur in CoA [22-24]. The expression of SM
contractile proteins may offer an accurate indication of the differentiation state, particularly the
expression of SM α-actin (SMA), SM myosin (SMM), and non-muscle myosin (NMM) in the
thoracic aorta [25]. Elevated levels of the markers SMM and SMA are direct indications of fully
differentiated, mature SMC’s; signifying normal vascular structure and function [22]. While nonmuscle in classification, NMM isoforms are present in SM and play essential roles in SM
contraction and cell-cell signaling through a proposed mechanosensitive pathway [26]. Due to its
direct link to cell proliferation and migration NMM is crucial during fetal development, but has
been shown to be expressed less in mature animals [27, 28]. Therefore, NMM expression may
provide a link between the mechanical stimuli observed in CoA and the resulting morbidity seen
clinically after repair.
Due to their unique position between the blood and smooth muscle cells, endothelial cells
play a vital role in cell to cell signaling in arteries via membrane receptors, along with the
regulation of vascular tone [20]. Research has also shown that WSS plays a crucial role in both
endothelial-dependent vasodilation and the regulation of vessel diameter and wall thickness [19,
29]. Increasing the WSS, which results from an increase in blood flow, triggers the release of
nitric oxide (NO) from the endothelial cells. NO subsequently causes vessel dilation which allows
for the WSS to return to homeostatic levels [30]. Additionally, a sustained decrease in vessel
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diameter due to a reduction in blood flow has been associated with a decrease in the elastin
content of the arterial wall, thereby increasing stiffness [31]. On the other hand prolonged,
abnormally high levels of WSS lead to an increase in vessel diameter and wall thickness to
maintain the homeostatic stress level of the vessel [32]. A return to physiological levels of WSS
allows the vessel diameter to return to normal size, however local alterations in WSS and medial
thickening still persist [19, 20]. Once vascular remodeling occurs due to elevated wall tension, the
blood vessels are unable to return to their original structure, even if the BP levels are returned to
normal physiological values [19]. These structural alterations due to abnormal mechanical stimuli
are possible causations of the high morbidity observed in repaired CoA patients.

1.4 The influence of altered structure on vascular function

It is possible that non-physiological levels of strain, wall tension, and WSS can damage
the endothelium, leading to the altered regulation of vascular tone and receptor-mediated cell
signaling mentioned previously [33]. In particular, the impaired endothelium-dependent
vasodilation to NO release is a recognized consequence of hypertension [34]. Due to its affinity
for a receptor on endothelial cells directly involved with NO release into the adjacent SMC,
acetylcholine (ACh) is a commonly used vasodilator to evaluate endothelial function [35, 36]. For
comparison, it is also possible to evaluate the endothelium-independent SM relaxation. For this
reason, sodium nitroprusside (SNP) is an ideal vasodilator to use since it radicalizes to create
spontaneous (i.e. endothelial independent) NO production in smooth muscle [37]. SM contraction
is indicative of the stiffness and compliance of the artery, and has been associated with the risk of
CVD [38]. Phenylephrine (PE) is a common vasoconstrictor, as it causes SM contraction via
binding to the α1 adrenergic receptor and consequential calcium release [39]. In combination,
these agents not only elucidate endothelium function, but also provide an indication of vessel
stiffness.
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In conjunction with endothelial dysfunction, the medial thickening and arterial
remodeling attributed to altered wall tension and WSS on the vessel wall could have an adverse
effect on the SM function, possibly due to the change in phenotype and decrease in elastin
content mentioned previously.

1.5 Previous findings using an animal model of CoA with a 20 mmHg BPG

Previous studies conducted using a CoA rabbit model, explained in further detail in the
methods section, explored the effects of a 20 mmHg BPG on vascular remodeling and resulting
variations in function. Three experimental groups were examined: control, CoA, and corrected.
The CoA group represented the case where no surgical correction to the coarctation was made,
while the corrected group mimicked surgical treatment to the CoA after exposure to the
mechanical stimuli of CoA for 21 days.
The 20mmHg BPG caused increased BP and tensile stress in the arteries proximal to the
CoA, while the WSS was decreased proximally at a few localized regions, but particularly
increased in many of the distal locations studied [25]. These altered mechanical stimuli lead to a
change in the NMM and SMM expression in proximal regions, delineating a change in SM
phenotype to the de-differentiated state [25]. Furthermore, the medial thickness was increased
throughout the proximal vasculature, substantiating vascular remodeling [25]. Consequently,
functionality was altered as observed by a decrease in vessel contractility to PE, and impaired
endothelial-dependent relaxation to ACh [25]. Increase in WSS distally due to the stenotic jet
caused impaired endothelium driven relaxation to ACh, while also increasing the endotheliumindependent relaxation to SNP [25].
In corrected rabbits, the increased medial thickness seen in CoA rabbits in combination
with the altered SM phenotype shift persisted [25]. Similarly, the endothelium remained
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dysfunctional in the proximal arteries, along with decreased vessel contractility to PE [25]. These
results suggest that the ramifications of pronounced mechanical stimuli many provide an
explanation for the long-term morbidity in CoA, and that the current clinical treatment guideline
may need to be altered to more effectively limit the likelihood of altered vascular function in CoA
patients [25].

1.6 Natriuretic peptide receptor C (NPR-C)

A preliminary study conducted by our group using RNA sequencing found a
downregulation of NPR-C in proximal aortic tissue compared to distal aortic tissue of humans
with CoA [80]. These results suggested NPR-C regulated vascular functions as a possible
mechanistic explanation for CoA-induced morbidity. Natriuretic peptides (NP) are a family of
hormones that have a vast array of physiological effects, each type having its own characteristic
function. The three primary peptides include atrial natriuretic peptide (ANP), B-type natriuretic
peptide (BNP), and C-type natriuretic peptide (CNP). ANP and BNP are secreted primarily from
the atria and ventricles, respectively, while CNP is primarily produced in the vascular
endothelium [40]. Important physiological roles of ANP and BNP include an increase in
natriuresis and diuresis, suppression of the renin-angiotensin-aldosterone system, and modulation
of blood pressure through vasodilation [41]. CNP is not believed to have as large of an effect as
ANP and BNP on the renal system, but it has been shown to be a potent vasodilator through a
paracrine effect on smooth muscle cells via endothelial cells [42]. In conjunction with these three
NP’s, there are three membrane NP receptors (NPR) consisting of NPR-A, NPR-B, NPR-C [40].
While all three NP’s bind to NPR-A and NPR-B, the order of binding affinity is suggested to be
ANP ≥ BNP >> CNP and CNP >>ANP ≥ BNP, respectively [40]. Binding to NPR-A and NPR-B
causes the particular physiological effects to occur through the activation of particulate guanylyl
cyclase (pGC). Conversely, NPR-C carries out its physiological effects via Gi protein activation
with the preferential binding affinity of ANP > CNP ≥ BNP [40, 43]. The activation of the Gi
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protein results in a coupled effect in four known signaling pathways (Figure 3). These include the
activation of endothelial nitric oxide synthase (eNOS) to produce NO, the inhibition of adenylyl
cyclase resulting in reduced cyclic adenosine monophosphate (cAMP) levels, the activation of the
enzyme phospholipase C (PLC) which results in a change in Ca2+ concentration, and attenuation
of mitogen-activated protein kinase (MAPK) that controls cell proliferation [43].

Figure 3. Summary of NPR-C-coupled signaling systems (Adapted from AnandSrivastava 2004) [43].

NPR-C is expressed throughout the vasculature, residing on both endothelial cells and
SMC’s [40]. There are conflicting reports as to how the activation of NPR-C produces a
vasorelaxation effect, with some groups suggesting it is through endothelial NO release via
activation of eNOS and others suggesting it is independent of NO and the effect is due to a
hyperpolarizing effect [44-51]. It has also been suggested that it can be both, depending on the
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particular vascular location, but it is noteworthy that all reported NPR-C mediated vasorelaxation
was dependent on intact endothelium [44-51].
Due to their vasorelaxive effects when bound to NPR-C, ANP and CNP can be used to
determine endothelial dysfunction with regards to NPR-C bioavailability. ANP has the highest
binding preference for NPR-C and has been linked to endothelium-dependent vasorelaxation, by
increasing eNOS activity [52, 53]. Conversely, ANP has also been shown to have an identical
endothelium-dependent relaxation effect through binding to NPR-A/B rather than NPR-C [5456]. In recent studies CNP has been shown to have a prominent impact on endothelium
vasorelaxation when bound to NPR-C by increasing NO production, and this relaxation is
impaired in spontaneously hypertensive rats (SHR) [49-51]. Due to the ability of all the NP’s to
bind to all the NPR’s it has been difficult to determine the exact combination of NP and NPR that
causes physiological effects historically. However, the development of a specific NPR-C
antagonist M372049, along with NPR-C specific agonist cANP, have allowed for more extensive
research into the specific roles of NP and NPR combinations in relation to cardiovascular effects.

1.7 Computational fluid dynamics (CFD) analysis of mechanical stimuli

Ongoing advancements in computational modeling and computational power have led to
an increasing usage of CFD as a research and clinical tool. In the case of cardiovascular research,
current CFD capabilities allow for extremely accurate predictions of 3D hemodynamic and
biomechanical indices without the need for invasive procedures. Examples of this include the
ability to model the inlet as a temporally-varying flow waveform based on subject-specific phasecontrast MRI imaging, the outlet boundary conditions as 3-element Windkessel models created
from phase-contrast MRI imaging in conjunction with measured BP data, and incorporating the
material properties of blood vessels into simulations to be able to model the vessels as deformable
[57-59]. The resulting CFD models allow for accurate physiological estimations of BP and flow

11
distributions, from which various additional hemodynamic indices can be calculated and
visualized. As mentioned previously, BP, wall tension, and WSS are of particular interest when
studying the morbidity associated with CoA. The quantification of these mechanical stimuli
utilizing CFD for different severities of CoA, in conjunction with experimental data, will
hopefully elucidate the threshold of irreversible alterations in vascular structure and function.

1.8 Specific aims

Aim1: Determine the threshold (severity and duration) of mechanical stimuli for irreversible
vascular remodeling in conjunction with endothelial dysfunction.

Current treatment guidelines of CoA are based on the BPG, of which a 20 mmHg is the
putative severity for intervention. Previous data using an animal model of CoA model with a 20
mmHg BPG revealed persistent vascular changes including increased medial thickness and
stiffening, a phenotypic shift in SMC to the de-differentiated proliferating state, and endothelial
dysfunction [25]. Importantly, all of these adverse changes persist despite correction of the
coarctation [25]. This aim will identify the threshold for these vascular alterations by determining
the level of mechanical stimuli that avoids the adverse vascular changes. Specifically, the severity
and duration of coarctation will be varied within ranges seen clinically (5, 10 and 20 mmHg as
well as 7 and 21 days, respectively).
Aim 2: Correlate the persistent arterial changes caused by CoA with NPR-C expression and
activity.

This aim is motivated by the preliminary RNA sequencing studies conducted by our
group indicating that NPR-C is downregulated in the region proximal to the CoA compared to
distal locations in both rabbit and human tissue samples [80]. NPR-C activation leads to
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vasorelaxation, dependent on intact endothelium in a suggested NO mechanism; similar to ACh.
To determine the correlation of this potential underlying mechanism to arterial changes, the
expression of NPR-C will be quantified along with NPR-C functionality in each of the
experimental groups described in Aim 1.
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CHAPTER 2: METHODS
2.1 Surgical protocol for inducing CoA in rabbits

After IACUC approval for protocols under the direction of Dr. LaDisa (AUA1175 at the
Medical College of Wisconsin; MU deferred AR=223), 10-week-old male New Zealand white
rabbits were randomly assigned to an experimental group; Control, Corrected CoA, or Native
CoA. The animals in surgical groups were assigned a severity of 5 mmHg, 10 mmHg, or 20
mmHg BPG. Additionally, the rabbits in the corrected group were assigned a duration for the
CoA of 7 days or 21 days, based on the length of time that the manufacturer suggests 50% of the
suture strength of will remain in both Rapide (7 days) and normal (21 days) Vicryl suture. An
overview of the experimental protocol explained above is shown in Figure 4. Rabbits undergoing
surgery were anesthetized using a combination of 22 mg/kg ketamine and 2.5 mg/kg that was
administered intramuscularly. After allowing the anesthesia to take effect, the rabbits underwent
endotracheal intubation and anesthesia was maintained by ventilating with 1-2% isoflurane.
Cefazolin (20mg/kg) and buprenorphine (0.025mg/kg) were administered subcutaneously prior to
the first incision for antibiotic and analgesic purposes, respectively. The fur above the 1st through
8th intercostal spaces was shaved and prepped for surgery using an antiseptic solution. A left
thoracotomy was performed in the 3rd intercostal space, and connective tissue was carefully
dissected around until the descending thoracic aorta was exposed. 4-0 permanent silk suture
(Native CoA), 4-0 dissolvable Vicryl suture (Corrected-21 days), or 4-0 Vicryl rapid dissolvable
Rapide suture ( Corrected-7 days) was tied around a stainless-steel wire of known diameter
(1.6mm for 20mmHg BPG; 2.0mm for 10mmHg BPG; 2.6mm for 5mmHg BPG). Careful
removal of the wire resulted in a discrete CoA of repeatable and known severity. The
pneumothorax was evacuated by placing a small, flexible tube in the pleural cavity and applying
suction with a three-way stop cock after the chest was closed in layers. Furosemide (5mg/kg) was
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administered subcutaneously postoperatively to treat any ensuing congestive heart failure or
edema. The tube was removed approximately 1.5 hours after surgery completion, when no more
fluid or air could be evacuated. The rabbit was allowed to recover from anesthesia for another 3-4
hours, until alert and active, and was then returned to their long-term housing unit.

Figure 4. Overview of the experimental protocol.

2.2 Post-procedure monitoring
Quantitative criteria including temperature, oxygen saturation, respiration, and pulse
along with qualitative criteria such as mucous membrane color and capillary refill time were
monitored every 10 minutes during surgery, as well as every 30 minutes for 4-5 hours postoperatively. Cefazolin and buprenorphine were continually administered twice a day, for two
days following completion of the surgery. Furosemide was continually administered twice a day
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on weekdays and once a day on weekends for two weeks post-operatively, or as directed by a
veterinarian to treat any resulting issues. Evaluations were conducted 2, 3, 5, 10, and 14 days
after surgery. During these observations, qualitative observations were made on the animal’s
attitude, appetite, drinking, urination, defecation, and vomiting along with surgical site
observational criteria such as appearance, swelling, drainage, hemorrhage, color, and incision
condition. The quantitative criteria mentioned above were also conducted on these checkup days
to ensure successful recovery from the surgery.

2.3 Ultrasound monitoring of CoA
After being re-anesthetized with isoflurane according to the approved IACUC protocols
above, rabbits were maintained on 2% isoflurane using a nose cone. The fur on the chest and
region surrounding the armpit was carefully shaved allowing for an unobstructed interface of gel
between the skin and the ultrasound transducer 11 MHz M12L linear array (GE Healthcare,
Waukesha, WI). Long axis 2-D, color Doppler, and pulsed spectral Doppler images were
obtained from the area above, through and below the coarctation region; along with the measured
peak velocity in these regions. The degree of angle correction was recorded for each animal, and
this angle was repeated for all subsequent exams. Imaging took less than 10 minutes for each
rabbit, and they were allowed to recover from anesthesia for another 1-2 hours until alert and
active. The peak velocity measurements were used to estimate the instantaneous peak BPG
utilizing the modified Bernoulli equation:
2
∆Ppeak = 4Vpeak

Ultrasound imaging was repeated every week until the BPG for each individual rabbit was
equilibrated. The approximated BPG obtained from the modified Bernoulli’s equation via
ultrasound imaging was only used to confirm the duration of CoA in the Corrected rabbits. 3
rabbits from the CoA and both Corrected groups were used in the data analysis.
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2.4 Intravascular blood pressure measurements, euthanasia, and tissue harvest

When the rabbits had matured to at least 32 weeks of age, they were anesthetized once
again using isoflurane. Due to the non-survival nature of this procedure, a tracheotomy was
performed for administration of anesthesia and ventilation. The fur above the left carotid and left
femoral arteries was shaved, and careful dissection was performed to reveal each artery. Fiveinch-long, fluid filled catheters were then inserted into each artery and carefully advanced to
reach the aorta. Proximal and distal blood pressure waveforms were then measured
simultaneously using identical transducers (Harvard Apparatus, Holliston, MA), and the
waveforms were digitally recorded at 720 Hz using a computer interfaced with an analog-todigital converter. During the entire procedure the same vitals as the survival surgeries, described
above, were recorded every 15 minutes. Following the conclusion of the BP recordings, the
rabbits were humanely euthanized according to the approved IACUC protocol. Following
euthanasia, the tissues and organs of interest were dissected and immediately placed in cold (4° C)
physiological salt solution (PSS; in mM: 140 NaCl, 4.7 KCl, 1.2 MgSO4, 1.6 CaCl2 ,1.2 NaHPO4,
2.0 MOPS adjusted to pH 7.4).

2.5 Myography

Arterial rings for experimental purposes were dissected from the locations
illustrated in Figure 5, and the area near the CoA was avoided so that vascular damage
due to surgery did not play a role in experimental outcomes. The rings were cut to 3mm
lengths, removed of adhering tissue and fat, and mounted on tungsten wire hooks in a
water-jacketed isometric myograph. Samples were maintained in PSS at 37° C and
bubbled continuously with 95% O2 5% CO2.
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Initially, tissues were allowed to equilibrate at a minimal resting tension for one
hour with one change in the PSS at the 30 min mark. Arteries were then stretched to a
working tension of 2g and 0.75g in aorta and carotid/femoral rings, respectively. This
working tension was determined from previous studies on the functional length vs.
active/resting force ratio, and was confirmed with length-tension data acquired from 12
rabbits [60-62]. To ensure tissue viability and create a baseline contraction response, tissue rings
were contracted using high potassium PSS (KPSS, [K] =109mM vs. 4.7mM in PSS). Activation
to KPSS was allowed to commence for five minutes, until the plateau of contraction force was
reached, and then tissues were rinsed with PSS three times and allowed to return to resting force.
This process was repeated two additional times until a consistent force response was reached.
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Figure 5. Diagram of the location of tissue sections used for myograph, histology, and
immunohistochemistry (IHC) experiments.

Following equilibration to resting force arterial rings were stimulated with cumulative
doses of PE (10-8 to 10-4.5 M). The effective force response to each PE dose was normalized to the
respective tissue’s maximum KPSS contractile response to account for differences in size and

19
cross-sectional area. Cumulative dose response curves were then created utilizing this normalized
PE contraction force.
After conclusion of the PE contraction experiments, tissues were washed three times with
PSS and again allowed to relax to resting tension. Endothelial-dependent and independent
vasorelaxation was determined with increasing concentrations (10-9 to 10-5 M) of ACh and SNP,
respectively. Prior to both ACh and SNP dose responses samples were pre-contracted with 0.5
μM PE, and response curves were constructed as percentages of active relaxation from precontracted tension. Following each dose response arteries were washed three times with PSS and
allowed to relax to resting tension.
Following ACh and SNP relaxation experiments, NPR-C driven relaxation was studied
via increasing doses (10-9 to 10-6 M) of CNP, cANP, and ANP. Vessels were pre-contracted with
0.5 μM PE prior to each dose response, and response curves were again constructed as
percentages of active relaxation from pre-contracted tension. Likewise, after the conclusion of
each dose response samples were rinsed with fresh PSS three times and equilibrated to the resting
tension. To further elucidate NPR-C derived relaxation, arteries were incubated in the NPR-C
specific inhibitor M372049 (10 μM for 30 min), after which additional CNP and ANP dose
responses were conducted identically to those previously mentioned. Response curves were also
constructed in an equivalent manner.
Drugs were obtained from the following sources: PE, ACh, SNP, and cANP from Sigma
Chemical Co (St. Louis, MO); ANP from GenScript (Piscataway, NJ); CNP from Bachem
(Torrance, CA); and M372049 from AstraZeneca (USA).

2.6 Vascular sectioning
The same vascular tissue rings that were used in the myograph experiments were
carefully removed from the experimental apparatus and stored overnight in 4° C PSS. The
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following morning each of the experimental tissue rings was wrapped in a small piece of skeletal
muscle for mechanical support, and subsequently frozen in liquid nitrogen and stored at −80° C .
8 µm cross-sectional slices were conducted on a Leica CM 1900 cryostat, mounted on glass
slides, and stored at −20° C until used.

2.7 Histology

Hematoxylin and eosin Y (H&E) staining was used to accentuate the elastic laminae, and
allow for measurement of the medial thickness. Frozen sections were thawed at room temperature
for 10 min and immersed in hematoxylin (5g/L) for ~2 minutes. The hematoxylin was then
carefully rinsed off under running tap water, and the tissues were subsequently dipped into
distilled water followed by alkaline water. Samples were then submerged in tap water for 2-3
min. Following nuclei staining with hematoxylin, the tissues were slowly dehydrated by placing
them in 35% ethyl alcohol (ETOH) for 30 seconds, 70% ETOH for 1 min, and 95% ETOH for 2
min. The samples were then counterstained with eosin Y for 30 seconds, followed by a destaining
in 95% ETOH for 10-15 min. Complete dehydration was achieved in the arterial sections by
transferring them to 100% ETOH for 3 min, followed up with incubation in a 50/50 solution of
xylene and 100% ETOH for 3 min. To ensure clearance of ETOH before coverslipping, the
tissues were submerged in a final bath of pure xylene for 3-5 minutes. Immediately following
removal of the slides from the xylene the stained specimens were coverslipped.
Stained sections were observed under a Zeiss light microscope at 6.3X objective
magnification, and digital images were acquired for quantitative analysis. ImageJ was then used
to measure the medial thickness (distance between the interior elastic lamina and the exterior
elastic lamina) after calibrating for the proper magnification. These measurements were obtained
by drawing orthogonal lines across the vessel wall, accounting for the curvature (Figure 6). To
account for variations in the thickness throughout the circumference of the vessel, three lines
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were drawn orthogonal to the lumen and averaged in each area of interest, along with four
~equidistant areas of interest per section. These four areas of interest were subsequently averaged
to yield a single estimation of medial thickness for each rabbit’s tissue location.

Figure 6. Example of H&E stain and quantification of medial thickness. The black lines represent
the measurement of medial thickness, orthogonal to the lumen.

2.8 Immunohistochemistry (IHC)

Frozen sections were allowed to thaw at room temperature for 10 min and then fixed with
2% paraformaldehyde for 10 min, permeabilized in 0.5 % Triton X-100 for 10 min, and blocked
with 5 mg/mL bovine serum albumin (BSA) for one hour at room temperature. No additional
washing was performed, and after each of the steps the solution that was currently on the slides
was removed. Sections were then incubated with the primary antibody at 4° C overnight (~16
hours). The tissues were then reacted with the secondary antibody for two hours at room
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temperature. The tissues were incubated with DAPI (0.5 µM, for staining nuclei) for 30 minutes
at room temperature and coverslipped. Multiple washes were used after primary, secondary, and
DAPI incubation to avoid non-specific binding.
All immunoreacting solutions were made in PBS-Tween with 0.1% bovine serum
albumin (BSA) as carrier. Antibodies were obtained from the following sources: SMA, and SMM
from Sigma Chemical Co (St. Louis, MO); NM myosin from Biomedical Technologies Inc.
(Stoughton, MA); NPR-C from LifeSpan BioSciences Inc. (Seattle, WA) and a kind gift from Dr.
A. Alli (University of Florida College of Medicine); Cy2 and Cy3 secondary antibodies from
Jackson Immuno Research (West Grove, PA); and DAPI from Molecular Probes/Invitrogen
(Eugene, OR).
Observations were made with an Olympus IX70 microscope with epifluorescense
illumination. Digital images were acquired with a 16-bit Princeton Instruments camera controlled
through PCI board via IPLab for Windows. For quantification requiring the entire media of the
vessel images were taken with a 10X air lens, while endothelial cell quantification was assessed
on images using a 100X oil lens. Grayscale images were collected for SMM, SMA, NMM,
endothelial NPR-C, and smooth muscle NPR-C using the same light intensity and exposure time
for all samples of respective stains. For quantification of smooth muscle protein expression three
random, orthogonal, similar-sized regions of interest were drawn across the medial wall (Figure
7, Left). The mean grayscale intensity inside each of the three regions of interest was
subsequently averaged to represent the region. This was repeated in three additional ~equidistant
locations around the vessel, and again averaged, to produce an approximation of smooth muscle
protein expression in each rabbit. For the quantification of endothelial protein expression
however, free-hand traces around four randomly chosen, endothelial, dapi-stained nuclei were
used as regions of interest for quantification in each image (Figure 7, Right). Similar to the
smooth muscle quantification, the grayscale intensity of four regions of interest were averaged
together in each image, and again averaged across three additional images to yield an estimation
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of endothelial protein expression in each rabbit’s tissue. All quantified protein expression was
conveyed as the average value of staining intensity (arbitrary units) ± SEM.

Lumen

10 µM

100 µM

Figure 7. Representative grayscale IHC micrograph (10X) and quantification of protein
expression in smooth muscle, yellow boxes represent the regions of interest used for
quantification of average staining intensity (Left). Representative grayscale IHC micrograph
(100X) and quantification of protein expression in the endothelium, yellow traces represent the
regions of interest used for quantification of average staining intensity (Right).

2.9 Setup and workflow for CFD simulations of mechanical stimuli

A prior control rabbit CAD model of the aorta, and head and neck arteries, from Menon
et al. was used to create idealized CoA models for each of the BPG groups (5, 10, and 20 mmHg)
using CAD software (Geomagic)[25]. The known diameters of the wires used to induce the CoA
via surgery served as a guideline for the size of CoA that should be created in each CAD model.
An example of the virtual CoA model with inlet and outlet labels is shown in Figure 8.
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Figure 8. Overview of how virtual CoA models were created along with labeled inlet and outlet
vessels. RSA = right subclavian artery, RCCA = right common carotid artery, LCCA = left
common carotid artery, LSA = left subclavian artery.

Previously acquired PC-MRI flow data that corresponded to the control rabbit model was
used to create the inlet and outlet boundary conditions for each of the virtual CoA models [25]. In
particular, ascending aortic PC-MRI waveforms were mapped to the inlet face of CFD models
using a temporally varying parabolic flow profile [57]. The PC-MRI data from the head and neck
arteries were used in conjunction with measured BP data to create three-element Windkessel
model outlet boundary conditions [58, 59]. Simulations were performed using the physiologic
parameters in Table 1 while solving the conservation of mass, balance of fluid momentum and
vessel dynamics equations [57]. Additionally, vessels were modeled as rigid and blood was
assumed to be a Newtonian fluid with a density of 1.06g/cm3 and a dynamic viscosity of 4 cP.
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Distal Aorta

128,000

148,000

154,000

128,000

10,500

2.02E-06

1.74E-06

1.68E-06

2.02E-06

2.4541E-05

1,150,000

1,330,000

1,390,000

1,150,000

94,800

6.31

5.45

5.24

6.31

76.69

Table 1. Assumptions and parameters used in CFD simulations of the current thesis. RSA = right
subclavian artery, RCCA = right common carotid artery, LCCA = left common carotid artery,
LSA = left subclavian artery.

Initially, a mean simulation was run on each model using steady flow and a ~250,000
element isotropic mesh to ensure the results matched aimed pressures and flow distributions, and
that the gradient across the CoA coincided with the respective group. Following the initial
simulation, localized refinement of the mesh was performed using an adaptation method, which
regionally redistributed elements based on residual error of the prior CFD solution for each model
[63]. This anisotropic mesh was then used to run an additional mean simulation with deformable
vessel walls using steady flow and ~4 million elements. Finally, these results were then used to
initialize the flow domain for pulsatile simulations. The pulsatile simulations used the
aforementioned PC-MRI flow waveform and were run for 10 cardiac cycles, until the flow and
BP were periodic.
Upon completion of the simulations and verification that the BP and flow distributions
matched aimed values from clinical measurements, BP, time-averaged WSS (TAWSS), and

normalized wall tension were visualized using the open-source software Paraview (Kitware Inc.,
Clifton Park, NY). TAWSS was calculated over the last cardiac cycle as previously described
[64]. Specifically, TAWSS was computed at each node on the surface of the CFD mesh as:
T

1
𝑇𝐴𝑊𝑆𝑆 = | ∫ ⃑⃑⃑⃑⃑⃑⃑⃑⃑
𝑊𝑆𝑆 𝑑𝑡|
T
0
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where ⃑⃑⃑⃑⃑⃑⃑⃑⃑
𝑊𝑆𝑆 is the WSS vector at a node and T is the period of one cardiac cycle. In this study
wall tension was calculated as the product of vessel radius and mean BP, and was normalized to
the control model’s dimensions. Deformable simulations were generously completed by
colleagues at the University of Michigan (Desmond Dillon-Murphy PhD, Christopher Arthurs
PhD and Alberto Figueroa PhD) due to a transient absence of available computational resources
at our institution.

2.10 Statistical analysis

Funding for the current study was limited. Therefore, many of the experimental groups
had different numbers of rabbits, depending on the significance of the group, previously acquired
data, and the experiment that was conducted. Data are expressed as means ± standard error of the
mean (SEM). In the cases where there was only one rabbit’s data available for preliminary NPRC data, error was calculated using the number of experimental samples, while statistical
significance was determined using n=1. The concentration of the drug producing half the
maximal response, followed by a negative logarithm transformation, (pEC50) was determined
from the dose-response curves of each tissue. The maximal response (Emax) to a specific drug
was considered the maximum amplitude of response reached in the dose-response curves. The
statistical analysis was conducted using one-way multiple analysis of variance (ANOVA)
followed by Tukey-Kramer multiple comparison test. Changes within and between groups were
considered statistically significant when P<0.05.
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CHAPTER 3: RESULTS
3.1 Ultrasound imaging elucidates range when CoA is alleviated in corrected rabbits
Ultrasound studies were performed weekly to track the onset of the BPG and confirm
absorption of dissolvable Vicryl sutures used in creating coarctation for rabbits in the Corrected
group. CoA rabbits exhibited persistent narrowing and elevated blood flow velocity during each
weekly imaging session (Figure 9). On the other hand, the Corrected rabbits in the regular Vicryl
(21-day) group showed a similar initial increase in blood flow velocity and BPG that was then
alleviated, accompanying a return to near normal aorta diameters after 34±2 days (~5 weeks).
Likewise, Corrected rabbits in the Rapide Vicryl (7-day) groups exhibited a decrease in velocity
and return to baseline BPG and aorta diameter, but in 23±4 days (~3 weeks).
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Figure 9. Representative ultrasound images illustrating the narrowing of the aorta and resulting
blood flow at different time points after induction of CoA for both the CoA and Corrected groups.

3.2 Blood pressure measurements
Rabbits that were subjected to coarctation with silk suture demonstrated a significantly
higher mean BPG measured between the proximal and distal catheter locations when compared
with rabbits that were in the control or corrected groups, regardless of severity (Figure 10). The
mean BPG of the CoA-20 mmHg group (16 mmHg, n=1) was significantly higher than those of
the 7-day Corrected-20 mmHg BPG (1 ± 0.12 mmHg, n=2; P<0.05) and the 21-day Corrected-20
mmHg BPG (2 mmHg, n=1) groups. Similarly, the mean BPG of the CoA-10 mmHg group (11 ±
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1.80 mmHg, n=2) was significantly higher than those of the 7-day Corrected-10 mmHg BPG (2 ±
0.53 mmHg, n=4; P<0.05) and the 21-day Corrected-10 mmHg BPG (4 ± 1.67 mmHg, n=5;
P<0.05). The mean BPG of the CoA-5 mmHg group (9 ± 1.21 mmHg, n=3) was higher than
anticipated, and significantly higher than the Corrected-5 mmHg BPG group (1 ± 0.98 mmHg,
n=2; P<0.05), but still significantly lower (P<0.05) than the CoA-20 mmHg BPG group. The
Control group had a significantly lower mean BPG (1mmHg, n=1; P<0.05) than both the CoA-5
mmHg BPG and CoA-10 mmHg BPG groups. Statistically significant differences were not
observed between Control and CoA-20 mmHg BPG groups, likely as a result of small samples
sizes.

Figure 10. Mean blood pressure gradient (± SEM) from rabbits in each experimental group,
taken as the difference between fluid-filled catheter measurements in the carotid and femoral
arteries. *=CoA-20 significantly different (P<0.05) than Corrected-20 mmHg BPG (7 days).
◊=CoA-20 significantly different (P<0.05) than CoA-5. †=CoA-10 significantly different
(P<0.05) than Corrected-10 mmHg BPG (21 days). ‡=CoA-10 significantly different (P<0.05)
than Corrected-10mmHg BPG (7 days). Ⱡ=CoA-5 significantly different (P<0.05) than
Corrected-5 mmHg BPG (21 days). ¥=Significantly different (P<0.05) than Control. n=1 for
Control, CoA-20, 21-day Corrected-20; n=2 for 21-day Corrected-5, CoA-10, 7-day Corrected20; n=3 for CoA-5; n=4 for 7-day Corrected-10; n=5 for 21-day Corrected-10.

3.3 Blood pressure, wall tension, time-averaged wall shear stress
Blood pressure results from CFD simulations queried at peak systole, diastole, and mean
BP for the control, CoA-5, CoA-10, and CoA-20 groups are shown on the left side of Figure 11.
Although CFD is largely qualitative when used in the sense presented in the current work, there is
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a distinction in BP between the groups by visual inspection when examining the proximal aorta
during peak systole. In particular observations indicate control values of ~65mmHg, CoA-5
values of ~70 mmHg, CoA-10 values of ~95 mmHg, and CoA-20 values of ~120 mmHg.
Although not as distinct, there also appear to be distinctions between the groups in the proximal
aorta regions during the time period corresponding to mean BP (control and CoA-5 values ~65
mmHg, CoA-10 values ~70mmHg, and CoA-20 values ~100mmHg). Spatial distributions of the
normalized wall tension for the control and CoA groups are shown on the right side of Figure 11.
As expected the normalized wall tension (the product of local displacement and BP) follows the
same trend as BP, with an increase in the amount of elevated wall tension values in the proximal
region as the severity of CoA is increased. In the control model a high wall tension (~4000
dyn/cm) area is localized at the top of the arch, and as the severity of CoA is increased, this
region of high wall tension grows until it covers nearly the entire proximal aortic region in the
CoA-20 model. In both the BP distribution and normalized wall tension models there was no
difference in the distal aorta regions across the different experimental groups.

Figure 11. Simulation results showing the blood pressure distributions for each of the
experimental groups at systolic, mean, and diastolic time points in the cardiac cycle (Left).
Simulation results displaying the spatial distributions of normalized wall tension for each
experimental group (Right).
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The spatial distribution of TAWSS for the control, CoA-5, CoA-10, and CoA-20 groups
is shown in Figure 12. The control model shows minimal variation in TAWSS throughout the
aorta, with values of TAWSS less than 5 dyn/cm2. In all of the CoA models there are expected
high values (~25dyn/cm2) of TAWSS at the coarctation and along the outer wall of the distal
aorta, where the velocity jet from the coarctation impinges. There is also a visual increase in the
area of the region of high (~25dyn/cm2) wall shear stress in the distal aorta as the severity of CoA
is increased. To better distinguish this region of high WSS across the groups, WSS values were
plotted along a line positioned along the posterior wall, in identical locations for each model,
through the region of interest (Figure 13). The peak TAWSS values from this line plot are
different between every group, and the average TAWSS are significantly different (P<0.05)
between every group (Table 2).

Figure 12. Simulation results showing the spatial distribution of time-averaged wall shear stress
for each experimental group.
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Figure 13 (Left). Time-averaged wall shear stress down the length of the distal aorta outer wall,
where the variation in TAWSS is highest. Table 2 (Right). Peak and average (± SEM) TAWSS
values down the length of the distal aorta outer wall for each experimental group. *=significantly
different (P<0.05) than all other groups. Data for both acquired via a line plot distribution from
the same simulations in Figure 11.

3.4 Medial thickness in the aorta
Figure 14 shows the medial thickness measurements made on hematoxylin and eosin
stains of anatomically identical proximal and distal aortic sections from each experimental group.
In the proximal region both the CoA-10 and CoA-20 groups had significantly increased (P<0.05)
medial thickness compared to the control group. In the Corrected groups, only the 20 mmHg BPG
severity caused significantly (P<0.05) increased medial thickness in the proximal aorta. The
reduction in duration of CoA in the Corrected-20 groups resulted in a decrease in medial
thickening that was comparable to control values. Conversely, the reduction in duration for the
Corrected-10 groups resulted in an increase in medial thickness that was significantly (P<0.05)
higher than control values. In the distal aorta only the CoA-20 group had significant (P<0.05)
medial thickening compared to the controls.
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Figure 14. Medial thickness measurements (mean thickness ± SEM) from hematoxylin and eosin
stains conducted on sections of aorta proximal and distal to the coarctation in CoA groups, and
anatomically equivalent sections in corrected and control groups. *=significantly different
(P<0.05) than control. n=2 for 7-day Corrected-20, 21-day Corrected-20; n=3 for CoA-5, 21day Corrected-5, CoA-10; n=4 for 7-day Corrected-10, CoA-20; n=5 for Control, 21-day
Corrected-10.

3.5 Smooth muscle isoform expression in the aorta

NMM, SMM, and SMA stains were applied on similar tissue sections from the proximal
aorta of CoA and Corrected rabbits (Figure 15). The CoA-10 and CoA-20 groups had
significantly greater (P<0.05) NMM expression compared to control, and the CoA-20 group was
also significantly greater than the CoA-5 and CoA-10 groups. With alleviation of the coarctation,
proximal aortic tissues showed no significant increase in NMM expression. There were no
changes in the expression of SMM or SMA for any CoA or Corrected groups in the proximal
aorta.
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Figure 15. Immunohistochemistry staining of NMM, SMM, and SMA comparing respective
staining intensity (mean ± SEM) to the severity of BPG for control, CoA, and corrected rabbits.
Tissue sections were cut from the aorta, proximal to the CoA. * = significantly different (P<0.05)
than control. ◊ = significantly different (P<0.05) than CoA-5. † = significantly different (P<0.05)
than CoA-10. n=2 for 21-day Corrected-20; n=3 for CoA-5, 21-day Corrected-5, CoA-10; n=4
for CoA-20; n=5 for Control, 21-day Corrected-10.

In the distal aorta NMM and SMA staining intensity was not significantly different from
control values for the CoA and Corrected groups (Figure 16). While the SMM expression was
not significantly different than the control group in all the CoA groups in the distal aorta, the
Corrected-5 and Corrected-20 groups had significantly (P<0.05) increased SMM expression
compared to the control group.
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Figure 16. Immunohistochemistry staining of NMM, SMM, and SMA comparing respective
staining intensity (mean ± SEM) to the severity of BPG for control, CoA, and corrected rabbits.
Tissue sections were cut from the aorta, distal to the CoA. * = significantly different (P<0.05)
than control. n=2 for 21-day Corrected-20; n=3 for CoA-5, 21-day Corrected-5, CoA-10, 7-day
Corrected-20; n=4 for 7-day Corrected-10, CoA-20; n=5 for Control, 21-day Corrected-10.

Reducing the duration of coarctation severities for 10 mmHg and 20 mmHg groups did
not significantly alter the expression of NMM and SMA in proximal or distal aortic locations
(Figure 17). SMM expression in the proximal aorta was not changed with a change in the
duration of CoA. However, in the distal aorta reducing the duration in the 7-day Corrected-20
group decreased the SMM expression to control levels.
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Figure 17. Immunohistochemistry staining of NMM, SMM, and SMA comparing respective
staining intensity (mean ± SEM) to the duration of BPG for control, and corrected rabbits. Tissue
sections were cut from the aorta, proximal and distal to the CoA. * = significantly different
(P<0.05) than control. n=2 for 21-day Corrected-20; n=3 for 21-day Corrected-5, 7-day
Corrected-20; n=4 for 7-day Corrected-10; n=5 for Control, 21-day Corrected-10.

3.6 Resting force verification for myography experiments

Length-tension curves were determined in 12 rabbits (data not shown) to verify the most
effective resting force for the vessel reactivity experiments conducted by myography. In
particular, the resting tension that yielded the highest active tension (peak contraction tension –
resting tension) was recorded for every rabbit in the proximal and distal aorta, along with the
carotid and femoral arteries. These experiments resulted in potential new resting tension values of
11.5g for the aorta and 6g for the carotid/femoral tissues. These values were then implemented in
the protocols of 3 additional rabbits, comparing the results from similar experiments using the
previous resting tension (i.e. 2g and 0.75g resting tensions for the aorta and carotid/femoral
arteries, respectively) on one day and the new resting tension values on the following day. The
new, higher resting tensions resulted in decreased active contraction and relaxation to all drugs
used compared to the original, lower resting tensions (data not shown). Therefore, the original 2g
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and 0.75g resting tensions for the aorta and carotid/femoral vessels, respectively, were used as
they appeared to yield most consistent results moving forward.

3.7 Vessel contractility and vasorelaxation in the aorta

Vessel contractility to PE, endothelium-dependent relaxation to ACh, and endotheliumindependent relaxation to SNP dose response curves were conducted in similar proximal aortic
tissues for the CoA, corrected, and control groups (Figure 18). The normalized contraction force
to PE was significantly (CoA-20 = log [-5.5 to -4.5]; P<0.05, CoA-10=log [-6.5 to -5.5]; P<0.05)
decreased compared to the control group in the CoA-10 and CoA-20 groups. Additionally, the
pEC50 to PE was significantly lower (P<0.05) for the CoA-5 and CoA-10 groups compared to the
control group (Table 3). Following alleviation of the coarctation, the corrected rabbits exhibited
similar contractile responses compared to control rabbits. The endothelium-dependent relaxation
was severely impaired (P<0.05, log [-7 to -5]) in the CoA-20 group in comparison to the Control
group. Additionally, the maximum relaxation exhibited by the CoA-20 group was significantly
impaired (P<0.05) compared to the Control, CoA-5, and CoA-10 groups (Table 3). Following
alleviation of the BPG, the Corrected-20 group still showed significant impairment (P<0.05, log
[-7 to -5]) of endothelial-dependent relaxation to ACh compared to the Control and Corrected-5
groups. Endothelium-independent relaxation to the agonist SNP showed no significant
impairment in all the CoA or corrected groups compared to the control group.
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Figure 18. Active contraction (PE) and relaxation (ACh, SNP) curves for the severity of BPG
tested in anatomically equivalent proximal aorta rings from control, CoA, and corrected groups.
*=CoA-10 significantly different (P<0.05) than control. ◊=CoA-20 significantly different
(P<0.05) than control. †=CoA-20 significantly different (P<0.05) than CoA-5. ‡=CoA-20
significantly different (P<0.05) than CoA-10. Ⱡ=Corrected-20 significantly different (P<0.05)
than control. ¥=Corrected-20 significantly different (P<0.05) than corrected-5. Values expressed
as mean ± SEM. n=2 for 21-day Corrected-5, 21-day Corrected-20; n=3 for CoA-5, n=CoA-10;
n=4 for 21-day Corrected-10; n=5 for CoA-20 (1 from current work, 4 from previous work [25]);
n=6 for Control (2 from current work, 4 from previous work [25]).

Vessel contractility to PE, endothelium-dependent relaxation to ACh, and endotheliumindependent relaxation to SNP dose response curves were conducted in similar tissues from the
distal aorta of the CoA, corrected, and control groups (Figure 19). There was no significant
difference in peak contractile force for any of the CoA or corrected groups when compared with
the control group. However, the CoA-10 group had a significantly less pronounced (P<0.05)
contractile response in comparison to the control group at low doses of PE (log [-6.5 to -6]).
Interestingly, the CoA-20 group exhibited a significantly higher (P<0.05) pEC50 value than both
the CoA-5 and CoA-10 groups (Table 3). Similar to what was seen in the proximal aorta,
endothelium-dependent relaxation to ACh in the distal aorta for the CoA-20 group was severely
(P<0.05, log [-6.5 to -5]) impaired compared to the control group. Additionally, the CoA-20
group had a significantly (P<0.05) impaired ACh relaxation compared to the CoA-5 and CoA-10
groups. After an alleviation of the BPG, the distal aorta again followed the trend of the proximal
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aorta and exhibited significantly (P<0.05, log [-7 to -6]) impaired endothelium-dependent
relaxation to ACh in the Corrected-20 group when compared to the Control and Corrected-5
groups. Furthermore, the Corrected-10 and Corrected-20 groups both had significantly (P<0.05)
lower pEC50 values compared to the Control group (Table 3). Relaxation with the endotheliumindependent agonist SNP yielded no significant differences between all control, CoA, and
corrected groups in the distal aorta.

Figure 19. Active contraction (PE) and relaxation (ACh, SNP) curves for the severity of BPG
tested in anatomically equivalent distal aorta rings from control, CoA, and corrected groups.
*=CoA-20 significantly different (P<0.05) than CoA-10. ◊=CoA-20 significantly different
(P<0.05) than control. †=CoA-20 significantly different (P<0.05) than CoA-5. ‡=CoA-20
significantly different (P<0.05) than CoA-10. Ⱡ=Corrected-20 significantly different (P<0.05)
than control. ¥=Corrected-20 significantly different (P<0.05) than corrected-5. Values expressed
as mean ± SEM. n=2 for 21-day Corrected-5, 21-day Corrected-20; n=3 for CoA-5, n=CoA-10;
n=4 for 21-day Corrected-10; n=5 for CoA-20 (1 from current work, 4 from previous work [25]);
n=6 for Control (2 from current work, 4 from previous work [25]).

Vessel contractility to PE, endothelium-dependent relaxation to ACh, and endotheliumindependent relaxation to SNP dose response curves were conducted in similar proximal and
distal aorta tissues for the 7 and 21- day corrected, and control groups (Figure 20). In the
proximal aorta normalized contraction force was significantly diminished (P<0.05, log [-6 to 4.5]) in the 7-day Corrected-20 group in comparison to the Control group. The pEC50 to PE was
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also significantly (P<0.05) reduced as compared to control values in the 7-day Corrected-10, 7day Corrected-20, and 21-day corrected-20 groups (Table 3). In the distal aorta there was no
significant difference in vessel contractility across any of the groups. In the proximal aorta,
endothelium-dependent relaxation to the agonist ACh was significantly impaired (P<0.05, log [-7
to -5], pEC50) in the 7 and 21-day Corrected-20 rabbits in comparison to the controls (Table 3).
The proximal 7-day Corrected-10 group’s ACh Emax value was significantly (P<0.05) lower than
the controls’ (Table 3). Similar endothelium-dependent ACh relaxation impairment is seen distal
to the coarctation, with both the 7 and 21-day Corrected-20 groups’ endothelium-dependent
relaxation significantly impaired (log [-8 to -5] and log [-7 to -6] respectively; P<0.05) in
comparison to the Control group. Moreover, these groups presented lower ACh Emax (7-day
Corrected-20 = 38 ± 10; P<0.05 and 21-day Corrected-20 = 45 ± 20 vs. Control = 74 ± 3)
compared to control rabbits. The 7 and 21-day Corrected-10 along with the 7 and 21-day
Corrected-20 groups all demonstrated a lower ACh-dependent pEC50 (7 day Corrected-10 = 7.15
± 0.36, 21 day Corrected-10 = 6.95 ± 0.13; P<0.05, 7 day Corrected-20 = 6.16 ± 0.16; P<0.05, 21
day Corrected-20 = 6.57 ± 0.06; P<0.05 vs. Control = 7.42 ± 0.08) than the Control group. The
SNP-driven endothelium-independent relaxation in both the proximal and distal aorta showed no
significant difference.
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Figure 20. Active contraction (PE) and relaxation (ACh, SNP) curves for the duration of BPG
tested in anatomically equivalent proximal and distal aorta rings from control and corrected
groups. *=7 day Corrected-20 significantly different (P<0.05) than Control. ◊=21-day
Corrected-20 significantly different (P<0.05) than Control. Values expressed as mean ± SEM.
n=2 for 21-day Corrected-20; n=3 for 7-day Corrected-10; n=4 for 21-day Corrected-10, 7-day
Corrected-10; n=6 for Control (2 from current work, 4 from previous work [25]).
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Table 3. Contractile, endothelium-dependent, and endothelium-independent effect on vascular
reactivity in the proximal and distal aorta. * = significantly different (P<0.05) than control. † =
significantly different (P<0.05) than CoA-10. ‡ = significantly different (P<0.05) than CoA-5. ⱷ
= significantly different (P<0.05) than Corrected-5. ◊ = significantly different (P<0.05) than 21
day Corrected-10. Ⱡ = significantly different (P<0.05) than 7-day Corrected-10. Values
expressed as mean ± SEM.
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3.8 Vessel contractility and vasorelaxation in the carotid and femoral arteries

Vessel reactivity in the carotid artery, demonstrated via PE, ACh, and SNP dose response
curves, was studied in control, CoA, and corrected rabbits (Figure 21). Vessel contractility was
significantly (P<0.05) impaired in CoA-20 rabbits compared to control, CoA-5, and CoA-10
animals. Conversely, Corrected-20 rabbits exhibited a PE dose response that was not significantly
different than controls. Endothelium-dependent relaxation to ACh was not significantly different
than the control group in all CoA and corrected groups. Compared to the Control group the
relaxation to the agonist SNP was impaired in the CoA-20 group, with a pEC50 significantly
lower (P<0.05) than the Control group. In contrast, all corrected rabbits exhibited a relaxant effect
to SNP that was not significantly different than controls.

Figure 21. Active contraction (PE) and relaxation (ACh, SNP) curves for the severity of BPG
tested in anatomically equivalent carotid rings from control, CoA, and corrected groups. *=CoA20 significantly different (P<0.05) than Control. ◊=CoA-20 significantly different (P<0.05) than
CoA-5. †=CoA-20 significantly different (P<0.05) than CoA-10. Values expressed as mean ±
SEM. n=1 for 21-day Corrected-5; n=2 for CoA-20, 21-day Corrected-20; n=3 for Control,
CoA-5, CoA-10; n=4 21-day Corrected-10.

The contraction to PE and relaxation to ACh and SNP was examined in the femoral
arteries of control, CoA, and corrected rabbits (Figure 22). Femoral artery contractility in
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response to increasing doses of PE was not significantly different than the control group in all
CoA and corrected groups. The endothelium-dependent relaxation to ACh was significantly
(P<0.05, log [-8 to -7] increased at low doses in CoA-20 rabbits compared to control rabbits,
while CoA-5 and CoA-10 rabbits were not significantly different. The Corrected-5 group showed
significantly (P<0.05, log [-7 to -5]) increased endothelium-dependent relaxation to ACh. These
changes were not observed for the other corrected groups. Endothelium-independent relaxation to
SNP was significantly (CoA-5=log [-7 to -6]; P<0.05, CoA-10=log [-7 to -6]; P<0.05, and CoA20=log [-9 to -5.5]; P<0.05) increased in the CoA groups compared to the control group.
Conversely, only the Corrected-5 rabbits showed significantly (log [-6.5]; P<0.05) increased
endothelium-independent relaxation to SNP at a single dose compared to control rabbits.

Figure 22. Active contraction (PE) and relaxation (ACh, SNP) curves for the severity of BPG
tested in anatomically equivalent femoral rings from control, CoA, and corrected groups.
*=dCoA-5 significantly different (P<0.05) than Control. ◊=CoA-5 significantly different
(P<0.05) than Control. †=CoA-10 significantly different (P<0.05) than Control. ‡=CoA-20
significantly different (P<0.05) than Control. Values expressed as mean ± SEM. n=1 for 21-day
Corrected-5; n=2 for CoA-20, 21-day Corrected-20; n=3 for Control, CoA-5, CoA-10; n=4 21day Corrected-10.
In addition to severity, the duration of the CoA’s role in vessel reactivity was explored
via PE, ACh, and SNP cumulative doses in both carotid and femoral arteries of control, CoA, and
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corrected rabbits (Figure 23). A reduction in the duration of the coarctation in the Corrected-10
and Corrected-20 groups did not significantly alter vessel contractility to PE, and vessel
relaxation to both ACh and SNP in either the carotid or femoral arterial regions.

Figure 23. Active contraction (PE) and relaxation (ACh, SNP) curves for the duration of BPG
tested in anatomically equivalent carotid and femoral arterial rings from control and corrected
groups. Values expressed as mean ± SEM. n=1 for 21-day Corrected-5; n=2 for 21-day
Corrected-20; n=3 for Control, 7-day Corrected-20; n=4 for 21-day Corrected-10, 7-day
Corrected-10.
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Table 4. Contractile, endothelium-dependent, and endothelium-independent effect on vascular
reactivity in the carotid and femoral arteries. * = significantly different (P<0.05) than control. ◊
= significantly different (P<0.05) than CoA-5. † = significantly different (P<0.05) than CoA-10.
Values expressed as mean ± SEM.

3.9 Expression of NPR-C in smooth muscle and endothelium of control rabbits

IHC staining for NPR-C was conducted in control rabbit proximal and distal aortas, in
conjunction with carotid and femoral artery tissue sections (Figure 24). To gain a better
understanding of the overall vascular expression, both endothelial and smooth muscle staining
intensities were measured. There was no significant difference in the expression of NPR-C in
either the endothelium or smooth muscle throughout all areas of the vasculature studied.
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Figure 24. Immunohistochemistry staining of NPR-C comparing respective staining intensity
(mean ± SEM) to the cell type in control rabbits. Tissue sections were cut from the proximal and
distal aorta (relative to the CoA if it were to exist), and from the carotid and femoral arteries.
n=5 for all groups.

3.10 Expression of NPR-C in smooth muscle and endothelial samples of
experimental rabbits

NPR-C expression in the endothelium of proximal and distal aorta tissue sections was
quantified in control, CoA, and corrected rabbits (Figure 25). Both CoA-10 and CoA-20 rabbits
had significantly lower (CoA-20 = 66 ± 5 (P<0.05), CoA-10 = 83 ± 4 (P<0.05) vs. Control = 108
± 7) NPR-C expression in the endothelium than controls. Downstream from the coarctation NPRC staining intensity in the endothelium remained significantly lower (P<0.05) in the CoA-20
group compared to the control group, while the CoA-10 group’s increased to match that of the
control group. In corrected rabbits the removal of the CoA did not increase the expression of
NPR-C in the endothelium for tissue from rabbits in the Corrected-10 and Corrected-20 groups,
as their staining intensities remained significantly decreased (Corrected-10 = 81 ± 7; P<0.05,
Corrected-20 = 74 ± 5; P<0.05 vs. Control = 108 ± 7) compared to the control group. On the
other hand, in the distal aorta all the corrected groups had endothelial NPR-C expression that was
not significantly different than the control group. Reducing the duration of the CoA from 21 days
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to 7 days in the Corrected-20 and Corrected-10 groups produced NPR-C expression in the
endothelium that was not statistically different from that measure in control samples.

Figure 25. Immunohistochemistry staining of endothelial NPR-C comparing respective staining
intensity (mean ± SEM) to the severity and duration of BPG in control, CoA, and corrected
rabbits. Tissue sections were cut from the proximal and distal aorta. *=significantly different
(P<0.05) than Control. ◊=significantly different (P<0.05) than Corrected-5. †=significantly
different (P<0.05) than CoA-10. n=1 for CoA-20; n= 2 for 21-day Corrected-20; n=3 for CoA-5,
21-day Corrected-5, CoA-10, 7-day Corrected-20; n=4 for 7-day Corrected-10; n=5 for Control,
21-day Corrected-20.

Smooth muscle expression of NPR-C was evaluated in the proximal and distal aorta of
control, CoA, and corrected rabbits (Figure 26). The CoA-10 and CoA-20 rabbits showed
significantly decreased smooth muscle (P<0.05) NPR-C expression than in the control group for
the proximal aortic location. In the distal aorta the CoA-5 and CoA-20 groups showed
significantly decreased smooth muscle expression of NPR-C compared to the control group. With
the exception of the Corrected-20 rabbits, aortic smooth muscle staining intensity of NPR-C
proximal to the coarctation was significantly decreased in corrected rabbits (Corrected-5 = 32 ± 2;
P<0.05, Corrected-10 = 22 ± 2; P<0.05 vs. Control = 52 ± 3) compared to controls. Distal to the
coarctation, all corrected groups had significantly lower (P<0.05) expression of NPR-C than the
control group. Following a reduction in duration of the coarctation in the Corrected-20 and
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Corrected-10 groups, the expression of NPR-C in the smooth muscle was not significantly
different from that observed in the control group for both the proximal and distal aorta.

Figure 26. Immunohistochemistry staining of smooth muscle NPR-C comparing respective
staining intensity (mean ± SEM) to the severity and duration of BPG in control, CoA, and
corrected rabbits. Tissue sections were cut from the proximal and distal aorta. *=significantly
different (P<0.05) than Control. †=significantly different (P<0.05) than CoA-10. ‡=significantly
different (P<0.05) than CoA-20. n=1 for CoA-20; n= 2 for 21-day Corrected-20; n=3 for CoA-5,
21-day Corrected-5, CoA-10, 7-day Corrected-20; n=4 for 7-day Corrected-10; n=5 for Control,
21-day Corrected-20.

3.11 NPR-C derived vasorelaxation in the aorta

To elucidate the impact of CoA severity and duration on NPR-C derived relaxation, CNP,
cANP, and ANP cumulative dose responses were evaluated in the proximal aorta of CoA and
corrected rabbits (Figure 27). Furthermore, the tissues were incubated in an NPR-C inhibitor and
additional CNP and ANP relaxation was studied. The Emax due to CNP in CoA-10 and CoA-20
rabbits was not different, while both were impaired (CoA-10 = 67 ± 21, CoA-20 = 62 ± 7 vs.
CoA-5 = 93 ± 22) compared to results observed from CoA-5 rabbits. Both the 21 day and 7 day
Corrected-10 groups did not have significantly different relaxation to CNP when compared to the
CoA-10 group. However, the 21-day Corrected-10 group had significantly increased (P<0.05, log
[-7.5 to -6]) maximum relaxation to CNP as compared to the 7-day Corrected-10 group.
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Following incubation with the NPR-C inhibitor, the proximal aortic tissues from the CoA-20 and
21 day Corrected-10 groups had significantly less pronounced (P<0.05, log[-7.5 to -6]) relaxation
to CNP than without the inhibitor. At high doses (log [-6.5 to -6]) cANP-derived relaxation in the
CoA-20 group was significantly lower (P<0.05) than observed with the CoA-5 group. The 21-day
Corrected-10 group had a significantly (P<0.05) reduced maximum relaxation to cANP than the
7-day Corrected-10 group. Active relaxation to ANP was significantly less pronounced (P<0.05)
in CoA-5 rabbits than CoA-20 rabbits for the doses log [-9 to -7]. Following alleviation of the
BPG, there were no differences in the response to ANP for corrected groups, regardless of the
duration, which was analogous to that seen in the CoA-5 group. The addition of the NPR-C
specific inhibitor only significantly impaired ANP relaxation in the CoA-5 group.

Figure 27. NPR-C dependent active relaxation (CNP, cANP, ANP) curves for the severity and
duration of BPG tested in anatomically equivalent proximal aorta rings from CoA and corrected
groups. *=CoA-20 significantly different (P<0.05) with NPR-C inhibitor. ◊=CoA-20 significantly
different (P<0.05) than CoA-5. †=Corrected-10 (7 days) significantly different (P<0.05) with
NPR-C inhibitor. ‡=CoA-5 significantly different (P<0.05) with NPR-C inhibitor. Ⱡ=Corrected10 (21 days) significantly different (P<0.05) than Corrected-10 (7 days). Values expressed as
mean ± SEM. n=1 for CoA-20; n=2 for CoA-10, 21-day Corrected-10, CoA-5; n=4 for 7-day
Corrected-10.
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The role of NPR-C dependent vascular function was also examined in the distal aorta of
CoA and corrected rabbits via cumulative dose responses of CNP, cANP, and ANP (Figure 28).
CNP and ANP dose responses were also repeated a second time, after incubation with the NPR-C
inhibitor. The active relaxation response to CNP was not significantly different in any of the CoA
or corrected groups. The addition of the NPR-C inhibitor resulted in significantly impaired (CoA20=log [-8 to -6.5]; P<0.05, 21- day Corrected-10= log [-7.5 to -6.5]; P<0.05, 7-day Corrected-10
log [-6]; P<0.05) relaxation to CNP compared to without the inhibitor. The maximum relaxation
to cANP in the CoA-20 rabbit was significantly greater (P<0.05) than that seen in both the CoA-5
and CoA-10 rabbits (Table 5). The cANP dependent relaxation in the 7 and 21 day Corrected-10
groups showed no significant change in relaxation compared to each other and the CoA-10 group.
In response to increasing doses of ANP in the distal aorta there was no significant change in
relaxation across all the CoA and corrected groups. The addition of the NPR-C specific inhibitor
only significantly reduced the maximum relaxation to ANP in the CoA-20 group.

Figure 28. NPR-C dependent active relaxation (CNP, cANP, ANP) curves for the severity and
duration of BPG tested in anatomically equivalent distal aorta rings from CoA and corrected
groups. *=CoA-20 significantly different (P<0.05) with NPR-C inhibitor. ◊=CoA-20 significantly
different (P<0.05) than CoA-5. †=Corrected-10 (7 days) significantly different (P<0.05) with
NPR-C inhibitor. ‡=Corrected-10 (21 days) significantly different (P<0.05) with NPR-C
inhibitor. Values expressed as mean ± SEM. n=1 for CoA-20; n=2 for CoA-10, 21-day
Corrected-10, CoA-5; n=4 for 7-day Corrected-10.
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Table 5. NPR-C dependent effect on vascular reactivity in the proximal and distal aorta.
*= significantly different (P<0.05) than the respective drug without the NPR-C inhibitor.
† = significantly different (P<0.05) than CoA-5. ‡ = significantly different (P<0.05) than CoA10. ◊ = significantly different (P<0.05) than Corrected-10 (21 days). Values expressed as mean ±
SEM.

3.12 NPR-C derived vasorelaxation in the carotid and femoral arteries

It was also of interest to examine a potential role for NPR-C in vessel relaxation
produced by cumulative doses of CNP, cANP, and ANP in the carotid artery of control, CoA, and
corrected rabbits (Figure 29). Additionally, CNP and ANP dose responses were evaluated in the
presence of an NPR-C inhibitor. The maximal relaxant effect produced by CNP in CoA-5 and
CoA-20 rabbits was significantly impaired (CoA-5 = 69 ± 2; P<0.05, CoA-20 = 60 ± 1; P<0.05
vs. Control = 88 ± 4) compared to the controls. Similarly, the Emax from CNP in both corrected
groups were significantly lower (21-day Corrected-10 = 68 ± 1; P<0.05, 7-day Corrected-10 = 62
± 6; P<0.05 vs. Control = 88 ± 4) than the control group. The NPR-C inhibitor significantly
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impaired the Emax to CNP of the CoA-20, 21-day Corrected-10, and 7-day Corrected-10 groups.
There was no significant difference in vessel relaxation to cANP between all CoA and corrected
rabbits and the controls. ANP dose responses yielded significantly impaired (P<0.05) Emax and
active relaxation at higher doses (log [-7.5 to -6]) in the CoA-20 group of rabbits as compared to
CoA-5 rabbits (Table 6). The elimination of a 10 mmHg BPG, regardless of duration, resulted in
ANP vessel relaxation equivalent to that of the CoA-5 group. Inhibition of NPR-C with M372049
did not produce a significantly different relaxation response to ANP in all CoA and corrected
groups.

Figure 29. NPR-C dependent active relaxation (CNP,cANP,ANP) curves for the severity and
duration of BPG tested in anatomically equivalent carotid rings from CoA and corrected groups.
*=Corrected-10 (7-day) significantly different (P<0.05) with NPR-C inhibitor. ◊=CoA-20
significantly different (P<0.05) than CoA-5. †=Corrected-10 (21 days) significantly different
(P<0.05) with NPR-C inhibitor. ‡=CoA-20 significantly different (P<0.05) with NPR-C inhibitor.
¥=CoA-20 and CoA-5 significantly different (P<0.05) than Control. Ⱡ = 7-day and 21-day
Corrected-10 significantly different (P<0.05) than Control. Values expressed as mean ± SEM.
n=1 for Control, CoA-20; n=2 for CoA-5, 21-day Corrected-10, CoA-10; n=4 for 7-day
Corrected-10.

The ability of CNP, cANP, and ANP to induce relaxation of femoral artery segments in
control, CoA, and corrected rabbits was studied to determine a potential role for NPR-C in
downstream vasculature (Figure 30). The inhibition of NPR-C was also studied via M372049 in
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conjunction with CNP and ANP to further understand the role the receptor plays in vascular
reactivity. Relaxation to CNP, cANP, and ANP was not significantly different between all CoA
and corrected groups compared to the control group for the femoral arteries studied. The
inhibition of NPR-C resulted in significantly (P<0.05) impaired relaxation to CNP at lower doses
(log [-9 to -7.5]) in the CoA-20 group. Additionally, the inhibition of NPR-C resulted in a
significant (P<0.05) decrease in relaxation to ANP (CoA-20= log [-9], CoA-5= log [-8, -7 to -6],
21-day Corrected-10=log [-9 to -6]) in the CoA-20, CoA-5, and 21-day Corrected-10 groups.

Figure 30. NPR-C dependent active relaxation (CNP, cANP, ANP) curves for the severity and
duration of BPG tested in anatomically equivalent femoral rings from CoA and corrected groups.
* = CoA-20 significantly different (P<0.05) with NPR-C inhibitor. ◊ = Corrected-10 (21 day)
significantly different (P<0.05) with NPR-C inhibitor. † = CoA-5 significantly different (P<0.05)
with NPR-C inhibitor. Values expressed as mean ± SEM. n=1 for Control, CoA-20; n=2 for CoA5, 21-day Corrected-10, CoA-10; n=4 for 7-day Corrected-10.
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Table 6. NPR-C dependent effect on vascular reactivity in the carotid and femoral arteries. * =
significantly different (P<0.05) than the respective drug without the NPR-C inhibitor. ¥ =
significantly different (P<0.05) than control. † = significantly different (P<0.05) than CoA-5. ‡ =
significantly different (P<0.05) than CoA-10. ◊ = significantly different (P<0.05) than
Corrected-10 (7 days). Ⱡ = significantly different (P<0.05) than Corrected-10 (21 days). Values
expressed as mean ± SEM.

56

CHAPTER 4: DISCUSSION
4.1 Review of motivation for the current research

Previous results using the experimental model applied here showed that the current
treatment guideline of a 20mmHg BPG produces irreversible vascular changes, due to alterations
in the wall tension and WSS imparted on the arteries [25]. These included increased medial
thickness and stiffening, a phenotypic shift in SMC to the de-differentiated proliferating state, and
endothelial dysfunction; which all persisted despite correction. However, these findings do not
address the duration and severity of CoA that characterize the onset of arterial remodeling and
dysfunction after correction. One of the goals of the current work was to unveil the threshold of
mechanical stimuli associated with CoA that leads to vascular remodeling and dysfunction. Along
with the previously mentioned findings, RNA sequencing revealed a downregulation of NPR-C in
proximal aortic tissue when compared to distal aortic tissue in humans with CoA [80]. The
second goal of the current work was to yield preliminary results that could expose NPR-C
expression and activity as an elusive mechanism that plays a role in the persistent arterial
remodeling and dysfunction seen with CoA.

4.2 Review of investigation findings

Aim 1:
Idealized CoA models created from control rabbit PC-MRI and measured BP data
displayed a distinct increase in BP and coverage of high normalized wall tension in the proximal
aorta as the severity of CoA was increased. Increased BP and wall tension are known to cause
vessel wall thickening and stiffening, and these adverse vascular changes are linked to risk of
hypertension and aneurysm formation [18, 19]. Conversely, as the severity of CoA was increased
in the distal aorta CFD simulations yielded a significant increase in coverage of high TAWSS
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where the jet impinges on the vessel wall, along with a significant increase in peak and mean
TAWSS values. WSS determines endothelium-dependent SM relaxation and regulates arterial
wall thickness. Consequently, alterations in the WSS have been linked to atherogenesis and
inflammation in the vasculature [19, 20, 29, 32]. The computational models indicate that wall
tension is the mechanical stimulus that causes remodeling above the CoA, while WSS is the
primary contributor to remodeling below the CoA.
Mechanically-induced remodeling can lead to a loss of vessel compliance and stiffening,
known results of hypertension and indication of advanced atherosclerosis [5, 66, 67] . Of
importance to CoA, prior studies concluded that about half of the total arterial compliance is
located in the proximal thoracic aorta and that large artery stiffness is the dominant factor of CV
morbidity compared to vascular resistance, respectively [68, 69]. In accordance with the
normalized wall tension trend, there was a significant increase in medial thickness as the severity
of CoA was increased beyond 5 mmHg in the proximal aorta. Previous studies have shown that
increased aortic medial thickness, which leads to vessel stiffening, is the direct effect of a
hypertensive environment [24, 70]. Correction of the CoA prevented significant medial
thickening in the proximal aorta when the BPG was less than 20 mmHg. Reducing the duration of
the CoA from 21 days to 7 days yielded inconclusive results. The medial thickness was
significantly increased in the distal aorta of the CoA-20 group only, but following a correction
was restored to normal. NMM expression was significantly increased in proximal aorta tissue of
CoA groups, but a correction to the CoA within 21 days prevented this increased expression.
Distal aorta locations showed SM marker protein expression similar to that of the controls,
suggesting that vascular remodeling is not significant in this location. NMM staining results are
suggestive of elevated vessel stiffness and vascular remodeling, which are both indicative of
vascular disease [26, 27]. The increased wall thickness and NMM expression observed in the
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corrected rabbits confirms irreversible vascular remodeling due to the adverse mechanical stimuli
caused by CoA, even after repair.
Vessel contractility was impaired as a result of CoA with a severity greater than 5 mmHg
in proximal aorta locations. In contrast, distal contraction was restored in all CoA groups. Further
upstream from the coarctation, in the carotid artery, vessel contractility is significantly impaired
with a BPG more severe than 10 mmHg. Downstream, in the femoral artery, vessel contractility is
not significantly impaired due to CoA. Impaired vessel contractility indicates the loss of vessel
wall compliance and is indicative of CVD [38]. Endothelial dysfunction exists when the severity
of BPG is greater than 10 mmHg in the proximal and distal aorta; indicating hypertension is
present [34]. The endothelial dysfunction does not occur in arteries further away from the CoA,
and endothelial relaxation is increased in the femoral artery; possibly due to the increase in WSS
that consequently causes endothelium vasorelaxation. SM relaxation was not significantly altered
due to CoA in either the proximal or distal aorta. SM relaxation is not significantly changed in the
carotid artery, while it was significantly increased in the femoral artery when CoA was present.
The increase in SM relaxation downstream from the CoA was observed previously by Menon et
al., and is thought to be caused by increased NO release caused by the elevated WSS in this
region [25].
Following alleviation of the CoA, all significantly impaired vessel contractility is
recovered in the vasculature. Surprisingly, a reduced duration of the 20 mmHg CoA in the
proximal aorta resulted in significantly impaired contraction. This anomaly could be caused by
variability in actual BPG that was present after CoA induction combined with the low number of
experimental animals available, because previous data showed a significant impairment in arterial
contractility in the proximal aorta of the 21-day corrected-20 group [25]. Endothelial dysfunction
persists after correction to the CoA in the proximal and distal aorta with severities greater than 5
mmHg, and a reduction in the duration of CoA does not improve endothelium function.
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The Aim 1 results indicate that the altered wall tension associated with CoA causes
arterial wall thickening and a change in SM phenotype to the dedifferentiated state in the
proximal aorta when the BPG is larger than 10 mmHg, while WSS created insignificant
remodeling in the distal aorta. Consequently, arterial stiffness is significantly increased when the
BPG is 10 mmHg or larger in the vasculature proximal to the CoA, while all distal vascular
stiffness is unchanged due to CoA. Additionally, severe endothelium dysfunction in all regions of
the aorta exists when the BPG is greater than 10 mmHg, but does not extend to the carotid or
femoral arteries. Wall thickening is not reversed with a correction to a CoA with a 10 mmHg
BPG occurring after 7 days of induction, while SM phenotype is reverted back to the fully
differentiated state following the relief of a BPG greater than 10 mmHg within 7 days.
Combining previous findings from Menon et al. with the presented findings it is possible to
conclude that a removal of the coarctation yields a restoration in proximal vasculature compliance
if the BPG is 10 mmHg or less, while a BPG greater than 10 mmHg exhibits persistent arterial
stiffness [25]. Alleviation of the CoA within 7 days does not reverse endothelial dysfunction in
both proximal and distal regions of the aorta. It is also possible to qualitatively state that the
mechanical stimuli, arterial structure, and arterial function results for the CoA-5 group are
comparable to that of the control group.

Aim 2:
NPR-C located within both the endothelium and SM did not show a significant difference
in expression throughout the vascular regions studied. In the presence of CoA endothelial NPR-C
has significantly reduced expression if the severity of the CoA in the proximal aorta is greater
than 5 mmHg. Distally, aortic endothelium-based NPR-C expression is reduced due to CoA when
the BPG is larger than 5 mmHg. Following alleviation of the coarctation in corrected rabbits,
reduced proximal aortic endothelial NPR-C expression persists when the BPG is larger than 5
mmHg. A reduction in the duration of CoA appears to avoid the significantly altered expression.
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Correction to the CoA within 21 days restores all significantly reduced endothelial NPR-C
expression in the distal aorta. SM NPR-C expression in the aorta was lower in the presence of
CoA, with no discernable trend attributable to severity. A correction to the CoA did not increase
SM NPR-C expression, apart from the 20 mmHg BPG in the proximal region. This is most likely
due to the small sample size of data. Reducing the duration of the CoA resulted in increased
NPR-C expression in both the proximal and distal aorta, with expression becoming comparable to
control levels.
Vessel relaxation in the aorta, proximal to the coarctation, to CNP, cANP, and ANP was
increasingly impaired as the severity of CoA was increased; while the opposite trend existed in
the distal location. This increased relaxation in the distal aorta could be attributed to the increased
NO release due to increased WSS, similar to what is seen with the increased SNP relaxation in
this region. Maximum vessel relaxation in the carotid artery to CNP was decreased due to a CoA
more severe than 5 mmHg, while cANP showed no discernable difference in relaxation, and a
BPG greater than 5mm Hg displayed severe impairment to ANP. Further downstream from the
coarctation, in the femoral artery, CoA induction resulted in no significant difference in
relaxation to CNP, cANP, or ANP. Inhibiting the function of the NPR-C receptor in the presence
of CoA resulted in impaired CNP and ANP relaxation in all vasculature. While this report is
lacking some control NPR-C data, the CoA-5 group did display CNP, cANP, and ANP relaxation
in the aorta, carotid artery, and femoral artery that is comparable to control data from other
groups [51, 71].
The removal of a 10mmHg BPG after 21 days resulted in restored CNP and cANP
relaxation in the proximal aorta. Surprisingly, an identical correction after 7 days resulted in
decreased CNP and cANP relaxation, possibly due to the small sample size of this preliminary
data. Despite the fact that there was no CoA-10 mmHg data to compare to, both the Corrected-10
groups showed no impairment in ANP relaxation in the proximal aorta. In the distal aorta a
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removal of the 10 mmHg BPG did not significantly alter CNP, cANP, and ANP vasorelaxation,
regardless of the duration. Upstream from the aorta, in the carotid artery, the alleviation of a 10
mmHg did not restore impaired maximum CNP relaxation, while cANP and ANP relaxation was
unimpaired. On the other hand, in the femoral artery vasorelaxation to CNP, cANP, and ANP was
unaltered following the removal of a 10mmHg BPG. Inhibition of the NPR-C receptor following
the removal of a 10 mmHg BPG showed similar CNP and ANP vasorelaxation impairment to that
observed in the presence of CoA in all the vasculature.
In summary, the results from aim 2 suggest that in the aorta, endothelial NPR-C
expression is substantially decreased in the presence of CoA with a severity greater than 10
mmHg, and SM NPR-C expression is also significantly decreased when the severity is greater
than 5 mmHg. An alleviation of the CoA within 7 days does avoid significantly impaired NPR-C
expression in the aortic vasculature. Consequently, endothelial vasorelaxation initiated by NPR-C
activation is impaired in the aorta, proximal to the coarctation, when the BPG is larger than 5
mmHg. A correction to the CoA yields conflicting results, so further experiments are needed in
order to determine if the relaxation is restored. In the carotid artery, a CoA with a severity larger
than 10 mmHg still shows significant impairment. In all vasculature distal to the CoA all NPR-C
relaxation is unaffected by the adverse mechanical stimuli, and in some instances the relaxation is
actually improved.

4.3 Limitations

The most apparent limitation in this study was the relatively small sample size for each
experimental group, especially with the NPR-C preliminary data. If funding and resources
allowed it, doubling the sample size for each group would reduce a lot of error and likely further
delineate differences between experimental groups. The values of TAWSS and wall tension
acquired from the CFD simulations are based on idealized models of CoA. Although they provide
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a worthy baseline, the geometry and flow varies more amongst rabbits in reality, and would yield
different values for TAWSS and wall tension. There are various limitations with the NPR-C
related experiments and data. Perhaps most important, there are a lot of conflicting reports and
overall unknown functional characteristics/pathways involved with the NPs and NPRs in regards
to vascular function, along with no literature referring to rabbit vasculature. Pertaining to the
present study, both CNP and ANP have been shown to induce vasorelaxation via NPR-A/B
with/without NPR-C dual activation in multiple locations of the vasculature [46, 50, 55, 56, 7175]. It is plausible that CNP and ANP could be causing relaxation via binding to both NPR-C and
NPR-A/B since the NPR-C inhibitor did not always significantly reduce relaxation, and there
were no tests involving NPR-A/B inhibition. Additionally, there are studies that have found that
both CNP and ANP can induce vasorelaxation through all the NPRs in an endotheliumindependent manner for all locations of vasculature [46, 71, 73-76]. Although the apparent
association between endothelial dysfunction and impaired NPR-C relaxation in this study
suggests that NPR-C vasorelaxation is indeed mediated through the endothelium, it is possible
that some relaxation could be due to SM NPR activation. Since the experiments involved
submerging arterial sections into a bath, it is conceivable that CNP, ANP, and cANP could bind
to their respective receptors in both the SM and endothelium. Furthermore, the observed
downregulation of NPR-C in the distal aorta due to CoA did not coincide with the apparent
increase in function seen in the same region. A possible explanation for this is that agonist
binding is not the only thing that determines NPR-C function, and it has been shown that
phosphorylation of the receptor plays an important role in receptor function [77]. With this in
mind, it is possible that a decrease in NPR-C density does not adversely affect the function, but
rather the phosphorylation state has a larger impact on the downstream signal transductions of
NPR-C.
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As the mean BPG measurement results showed, the CoA-5 group had a mean BPG of 9
and the CoA-20 group had a mean BPG of 16, both higher and lower, respectively, than what
they were predicted to be. A possible explanation for this is the weight of the rabbits at the time
of the BP measurements, since a larger rabbit with the same-sized narrowing would probably
have a larger measured BPG. The rabbits’ weights at time of BP measurement were therefore
plotted against measured BPG (Figure 31). As the figure shows by visual inspection, there was a
trend towards decreased rabbit weight as the BPG was increased. This is a possible cause for the

Rabbit Weight (Kg)

CoA-5 rabbits having larger and the CoA-20 rabbits having lower BPG’s than were predicted.

Measured BPG (mmHg)
Figure 31. Rabbit weight compared to the measured mean BPG at the time of euthanasia in the
CoA groups only.

There were also several additional mechanistic pathways, agonists, and inhibitors tested
during the course of the current work that did not yield promising results. Prior to the discovery
of NPR-C downregulation by RNA sequencing as mentioned elsewhere in this work, we
investigated a similar decrease in the expression of the sarco/endoplasmic reticulum calcium
ATPase (SERCA) and tryptophan 2, 3-dioxygenase (TDO2) proteins in the proximal aorta of
CoA patients. Both targets were motivated by reanalysis of prior CoA rabbit microarray or copy
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number variant data [81, 82]. The SERCA protein is a crucial regulator for intracellular Ca2+
concentrations, while TDO2 metabolizes tryptophan to kynurenine in the endothelium to play a
role in arterial relaxation. SERCA pump function was evaluated by examining NO-dependent
relaxation to SNP following an incubation of experimental tissues in the selective SERCA
inhibitor cyclopiazonic acid (CPA). TDO2 function was determined by incubating experimental
tissues in the specific TDO2 inhibitor 680C91 prior to conducting dose response curves with
typtophan, kynurenine, and a combination of both. Both the inhibition of the SERCA pump and
TDO2 yielded no significant difference in functionality, prompting a search for a new
mechanistic approach applicable to CoA. The next formulated hypothesis was that the
hypertensive state of the proximal region in our model was creating an overabundance of reactive
oxygen species (ROS) that were causing altered vascular function. To test this theory,
experimental tissues were incubated in the antioxidants tempol, apocynin, polyethylene glycolcatalase, and polyethylene glycol-superoxide dismutase respectively, and endothelium-dependent
relaxation to ACh was examined. None of these antioxidants restored the observed impaired ACh
relaxation in the proximal regions of this model. In more recent experiments, in addition to NPRC investigation, a parallel molecular pathway involving smooth muscle relaxation driven by
endothelial cyclooxygenase (COX) activation and subsequent prostacyclin (PGI2) release into the
SM was investigated. The working hypothesis was that in a hypertensive environment there could
be either a decreased amount of PGI2 receptors in the SM or that there is an increase in the
activation of the endothelial COX via increased activation of B2 receptors. In either case the result
is an elevation in “free roaming” PGI2 which has an adverse effect on vasodilation. To test this
hypothesis we incubated experimental tissues in both the specific COX inhibitor indomethacin
and the specific B2 receptor antagonist HOE-140, and then conducted ACh dose responses to
determine endothelial function. Both drugs failed to restore vasorelaxation to ACh in the impaired
proximal regions of this CoA model, albeit for a limited number of samples.
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4.4 Future Studies

To more accurately characterize and quantify the mechanical stimuli involved with this
model of CoA, subject-specific simulations for every rabbit could be completed. For example,
each rabbit’s individual imaging data could be used to create subject-specific CFD models along
with subject -specific inflow and outlet boundary conditions. To become even more precise, the
simulations used to calculate TAWSS and BP could be modeled using a deformable wall for a
full cardiac cycle such as described in the wall tension FSI simulations using mean values.
Although this work is in progress now, the results should dictate a more physiological
representation of the mechanical stimuli present with the different severities of CoA.
In order to completely elucidate the function of CNP, ANP, and cANP have on NPR-C in
rabbit vasculature it would be beneficial to run experiments in which a NPR-A/B inhibitor is used
in all the same experiments as the NPR-C antagonist. This would allow for a more complete
understanding of the possible different roles of NPR-C in vasculature, depending on location and
severity of adverse stimuli. Additionally, to completely unravel the role of the endothelium vs SM
in NPR-C vasorelaxation tests could be done in which the endothelium is completely removed.
For instance an experimental protocol could be run on control tissue as usual, but then an
identical experiment could be done using the same tissue after removing the endothelium.
Furthermore, an understanding of the molecular mechanism causing the downregulation of NPRC would also lead to a better understanding of the entire mechanistic pathway. It has been shown
that abnormal glycosylation leads to the complete absence of NPR-C in the plasma membrane
[78]. As mentioned previously, the particular phosphorylation state of NPR-C could play a large
role in its function, so these findings suggest that an investigation into the post-translational
modifications of NPR-C could yield a better understanding of what controls the expression and
function of the receptor, respectively.
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An additional extension of this project, which is already well underway, is to correlate the
proposed threshold of 10 mmHg and potential NPR-C driven arterial changes found in rabbits
with CoA to human CoA patients. In particular, the BPG prior to correction of CoA along with
the most recent follow up BPG measurement will be correlated with the hypertension status of
human CoA patients. Additionally, NPR-C gene variations in these patients will also be
compared with the current hypertensive status of the patients. This study could establish a new
threshold for intervention of CoA along with a novel role for NPR-C dysfunction in the
development of hypertension in CoA patients, and further motivate the opportunity for a
therapeutic target for hypertension in general.

4.5 Clinical Significance

1) Collectively, the results from aim 1 suggest that adverse remodeling and dysfunction due
to CoA is present with a BPG of 10 mmHg or higher across the coarctation. The adverse
vascular effects persist, even after a correction to the CoA, if the alleviation isn’t
completed within 7 days. Additionally, from a qualitative standpoint the arterial structure
and function due to a CoA with a BPG of 5 mmHg is similar to control results. These
findings propose that a 10 mmHg BPG should be considered as the clinical threshold for
intervention.
2)

The preliminary results from aim 2 suggest that NPR-C expression is downregulated
throughout the aorta in the presence of a CoA more severe than the proposed threshold
mentioned previously. Furthermore, the reduced expression is not avoided following a
correction to the CoA. Consequently, vasorelaxation facilitated through NPR-C is
impaired in all vasculature proximal to a CoA more severe than the proposed threshold.
Further studies are necessary to determine if a correction to the CoA restores this
compromised NPR-C function. These findings suggest that NPR-C is a promising
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candidate as the underlying mechanistic interconnection to the arterial impairment
characteristic of CoA, and could be a favorable therapeutic target for hypertension in
general.
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